> Tumor necrosis factor has been a big focus of drug developers targeting a variety of inflammatory bowel diseases. Now a team at Duke says that "a gene called uhrf1 acts like a kind of molecular handbrake on TNF. In the absence of uhrf1, TNF rolls out a series of pro-inflammatory and immune signals that inflame and damage the digestive tract." Release
> UC Irvine investigators say that human neural stem cell therapies could help improve cognitive function after chemo. Release
> Mitofusin 2 looks valuable as a target for diseases linked to loss of mitochondrial fusion. Release
> Investigators are still focused on the role that cannabis can play in the development of new meds. Release